Wall Street brokerages expect Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) to announce earnings per share (EPS) of ($0.32) for the current quarter, Zacks reports. Four analysts have provided estimates for Sangamo Therapeutics’ earnings, with the lowest EPS estimate coming in at ($0.41) and the highest estimate coming in at ($0.13). Sangamo Therapeutics also posted […]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) – Investment analysts at Truist Financial lowered their FY2022 earnings per share (EPS) estimates for Sangamo Therapeutics in a research report issued to clients and investors on Monday, April 4th. Truist Financial analyst N. Germino now anticipates that the biopharmaceutical company will earn ($1.22) per share for the […]
Brokerages predict that Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) will post earnings of ($0.32) per share for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Sangamo Therapeutics’ earnings. The highest EPS estimate is ($0.13) and the lowest is ($0.41). Sangamo Therapeutics also posted earnings of ($0.32) per share […]
Analysts forecast that Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) will post ($0.38) earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Sangamo Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.33) and the lowest estimate coming in at ($0.43). Sangamo Therapeutics reported earnings […]
Sangamo Therapeutics, Inc (NASDAQ:SGMO) Expected to Announce Quarterly Sales of $29 15 Million etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.